Headliners from this year included Sampler’s Marie Chevrier Schwartz, who joined BetaKit’s editor-in-chief Douglas Soltys on The BetaKit Keynote Stage (BetaKit is a SAAS NORTH media partner), as well ...
The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure.